Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sasaki Y et al. | p53 negatively regulates the hepatoma growth factor HDGF. | 2011 | Cancer Res. | pmid:22006999 |
Chik CL et al. | Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. | 2011 | Mol. Cell. Endocrinol. | pmid:21704117 |
Li S et al. | Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. | 2011 | Mol. Cancer | pmid:21314984 |
Kumar A et al. | γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. | 2011 | Int. J. Radiat. Biol. | pmid:21815748 |
Stoppani E et al. | Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. | 2011 | Biochim. Biophys. Acta | pmid:21182936 |
Salvi V et al. | Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. | 2010 Sep-Oct | Immunobiology | pmid:20573419 |
Luo W et al. | Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. | 2010 | Cancer Res. | pmid:20587525 |
Zaman MS et al. | The functional significance of microRNA-145 in prostate cancer. | 2010 | Br. J. Cancer | pmid:20588276 |
Shu ST et al. | Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. | 2010 | Anticancer Res. | pmid:20651337 |
Paddock MN et al. | The BRCT domain of PARP-1 is required for immunoglobulin gene conversion. | 2010 | PLoS Biol. | pmid:20652015 |
Mossman D et al. | Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. | 2010 | BMC Cancer | pmid:20618997 |
Ma J et al. | Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. | 2010 | Carcinogenesis | pmid:20622005 |
Chen J et al. | Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. | 2010 | Epigenetics | pmid:20505343 |
Liu YW et al. | Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. | 2010 | J. Cell. Biochem. | pmid:20506344 |
Kitamoto S et al. | Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20510874 |
Liang Q et al. | The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers. | 2010 | Int. J. Cancer | pmid:20112338 |
Beedanagari SR et al. | Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. | 2010 | Toxicol. Lett. | pmid:20116417 |
Lu Y et al. | Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. | 2010 | Hum. Reprod. | pmid:20118114 |
Davies GF et al. | Troglitazone inhibits histone deacetylase activity in breast cancer cells. | 2010 | Cancer Lett. | pmid:19699029 |
Wu Y et al. | Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. | 2010 | BMC Cancer | pmid:20132554 |
Kim TH et al. | The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. | 2010 | Int. Immunopharmacol. | pmid:20728595 |
Aoyama M et al. | Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. | 2010 | Nutrition | pmid:20004081 |
Ji P et al. | Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. | 2010 | Haematologica | pmid:20823130 |
Nunes MJ et al. | Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. | 2010 | J. Neurochem. | pmid:20096088 |
Weng YI et al. | Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. | 2010 | Toxicol. Appl. Pharmacol. | pmid:20678512 |
Aizawa S and Yamamuro Y | Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. | 2010 | Neurochem. Int. | pmid:20100532 |
Tamannai M et al. | The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. | 2010 | Oncol. Res. | pmid:20681406 |
Wu J et al. | Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. | 2010 | Acta Pharmacol. Sin. | pmid:20048748 |
Sonnemann J et al. | Serine proteases in histone deacetylase inhibitor-induced apoptosis. | 2010 | Mol. Cancer Ther. | pmid:20682651 |
Hebbel RP et al. | The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. | 2010 | Blood | pmid:20053759 |
Fu J et al. | Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. | 2010 | Bioorg. Med. Chem. | pmid:21067930 |
He R et al. | Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. | 2010 | J. Med. Chem. | pmid:20055418 |
Nicodeme E et al. | Suppression of inflammation by a synthetic histone mimic. | 2010 | Nature | pmid:21068722 |
Xu J et al. | CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. | 2010 | Breast Cancer Res. Treat. | pmid:19466541 |
Watson JA et al. | Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. | 2010 | J. Cell. Mol. Med. | pmid:19583812 |
Song S et al. | Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. | 2010 | Cardiovasc. Res. | pmid:19633316 |
Eskeland R et al. | Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. | 2010 | Cold Spring Harb. Symp. Quant. Biol. | pmid:21502416 |
Zein S et al. | Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. | 2010 | Exp. Biol. Med. (Maywood) | pmid:20975082 |
Chao KC et al. | Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells. | 2010 | Eur. J. Gynaecol. Oncol. | pmid:20882882 |
Lee CS et al. | 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. | 2010 | Eur. J. Pharmacol. | pmid:20868669 |
Yuan GB et al. | Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells. | 2010 | Chin J Cancer | pmid:20346212 |
Wang QH et al. | Opposite effects of Trichostatin A on activation of mast cells by different stimulants. | 2010 | FEBS Lett. | pmid:20371366 |
Simboeck E et al. | A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. | 2010 | J. Biol. Chem. | pmid:20952396 |
Marumo T et al. | Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. | 2010 | Am. J. Physiol. Renal Physiol. | pmid:19906951 |
Yakovlev A et al. | Epigenetic regulation of caspase-3 gene expression in rat brain development. | 2010 | Gene | pmid:19909801 |
Freidkin I et al. | Effects of histone deacetylase inhibitors on rat mesangial cells. | 2010 | Am. J. Physiol. Renal Physiol. | pmid:19923417 |
Perisic T et al. | Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. | 2010 | Neuropsychopharmacology | pmid:19924110 |
Li X et al. | Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. | 2010 | Br. J. Haematol. | pmid:19807731 |
Ninios YP et al. | Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. | 2010 | Leuk. Res. | pmid:19782399 |
Higashiyama R et al. | Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. | 2010 | Mod Rheumatol | pmid:19784544 |